TrialCancer science2016

Prognosis of metastatic renal cell carcinoma with first-line interferon-α therapy in the era of molecular-targeted therapy.

Yoshiaki Kawano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.